Novartis seeks shareholder approval to spin off Alcon eye care business
Swiss drug-maker Novartis is planning to spin off its eye care division Alcon into a standalone company, which…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
02 Jul 18
Swiss drug-maker Novartis is planning to spin off its eye care division Alcon into a standalone company, which…
26 Jun 18
Royal Philips is showcasing its portfolio of molecular imaging solutions at the ongoing Society of Nuclear Medicine and…
22 Jun 18
South Korean in vitro diagnostics firm SD Biosensor has collaborated with the nonprofit organization PATH to advance the…
20 Jun 18
Roche has agreed to acquire remaining shares in Foundation Medicine (FMI), a US molecular and genomic analysis company,…
19 Jun 18
Micrima, a UK-based breast imaging company has secured £4.4m through a new equity funding round led by Technology…
19 Jun 18
Sweden-based Elekta has secured CE mark approval for its Unity magnetic resonance radiation therapy (MR/RT) system.
13 Jun 18
Fujirebio Diagnostics, a consolidated subsidiary of Miraca Holdings, has secured approval from the US Food and Drug Administration…
12 Jun 18
Medical device firm Optovue has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its…
07 Jun 18
US-based Fortive has made an offer worth around $2.7bn to acquire Johnson & Johnson’s (J&J) Advanced Sterilization Products…
07 Jun 18
Microbiotica has partnered with Genentech to discover, develop and commercialise biomarkers, targets and medicines for inflammatory bowel disease…